Frontotemporal degeneration, or FTD, is a neurodegenerative disease that manifests clinically as a change in behavior — affecting one’s personality — or a disorder of language, sometimes accompanied by motor weakness or involuntary movements. These symptoms are associated with the accumulation of a specific kind of pathologic protein in the brain, including tau or TDP-43.
Through the University of Pennsylvania’s Frontotemporal degeneration Program Project Grant (PPG), led by Virginia M.-Y. Lee, PhD, MBA, and Frontotemporal Degeneration Center, led by Murray Grossman, MD, EdD, a collaborative team of Penn Medicine researchers and clinicians strive to improve the lives of those affected by FTD.
Take a behind-the-scenes look at their work through our Virtual Tour:
To learn more about the Penn FTD Center, visit: ftd.med.upenn.edu
To learn more about the FTD PPG and related research, visit: http://www.med.upenn.edu/cndr